Donation

The IMF’s Understanding series of cancer information booklets is designed to acquaint you with specific multiple myeloma-related tests, treatments and therapies, supportive care measures, and common adverse events.

Due to current health and safety precautions, hard copy mailing of IMF publications are temporarily delayed up to several weeks. However, digital versions of all IMF publications are available below.

Order Print Edition

 

This publication focuses on therapies (such as bisphosphonates) given to patient with myeloma bone lesions, lytic lesions, or myeloma bone disease.
This publication discusses how myeloma patients can manage vertebral compression fractures.
This publication discusses the use of Velcade (bortezomib)—a proteasome inhibitor—for the treatment of myeloma.
This booklet will introduce you to Xpovio™ (generic drug name selinexor)
This publication outlines the tests used to diagnose and monitor myeloma.

We Thank Our Sponsors:
Amgen, Bristol-Myers Squibb, Genentech, GlaxoSmithKline, Janssen, Karyopharm, Sanofi, and Takeda Oncology

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.